Synergy Pharmaceuticals presents poster on SP-333

Synergy Pharmaceuticals presents poster on SP-333 Synergy Pharmaceuticals announced that a poster presentation on SP-333, Synergy's next-generation guanylate cyclase-C agonist to treat ulcerative colitis, will be made at the 2012 Advances in Inflammatory Bowel Diseases, Crohn's & Colitis Foundation's Clinical & Research Conference.


More...